MAM
GenY Medium wins digital mandate for O2 Spa
MUMBAI: GenY Medium (GenY) has become the digital partner of O2 Spa by winning the latter’s digital mandate. O2 Spa, the largest day spa chain in Asia is present at over 70 locations, across 21 cities in India. Over a period of 12 years, the brand has become synonymous with wellness and salon services of global standards. GenY Medium is a full-service digital agency that enhances the digital presence of leading businesses by combining the art of marketing with the science of digital.
In accordance with the requisites of the mandate, GenY will focus on Omni channel marketing and online to offline (O2O) commerce for bringing in quality prospects to their sales strategy and goals. O2 Spa has given GenY a full-service mandate which includes digital brand building, performance marketing and deployment of marketing technology systems.
GenY Medium co-founder & CEO Yashwant Kumar said, “We are looking forward to working with O2 Spa. Being a category leader implies that the brand will need to push the envelope on digital. This is what excites us. We believe that our experience in applying marketing technologies can help us add significantly to the business. Our performance-driven approach and focus on leveraging the right set of technologies will certainly deliver the desired business results for O2 Spa.”
O2 Spa chief executive officer Ritesh Reddy Mastipuram said, “As our audience is most active on digital, our primary channel will be digital to reach out and engage with our audience. We are excited about having GenY Medium on board as our digital partner, as we needed a partner who understands this challenge and has delivered before. Their expertise in the digital space, especially their ability to marry art and science gives us much to look forward to.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
